Qing Wang

发表

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

A. LeMaistre, M. Rivoire, P. Méeus, 2013, BMC Cancer.

Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study

F. Borson‐Chazot, A. Giraudet, P. Bringuier, 2016, Targeted Oncology.

Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study

Qing Wang, Zhiyong Sun, Xiaojing Zhao, 2022, BMC cancer.

Abstract GS1-10: Clinical utility of molecular tumor profiling: Results from the randomized trial SAFIR02-BREAST

I. Bièche, I. Soubeyran, F. André, 2022, Cancer Research.

BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic‐related mutations in BRCA1 associated with an increased risk of ovarian cancer

Q. Wei, Caixia Xie, Tingyan Shi, 2017, International journal of cancer.

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

A. LeMaistre, M. Rivoire, P. Méeus, 2013, BMC Cancer.

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

Q. Wei, Tingyan Shi, Wenbin Tang, 2018, Cellular Physiology and Biochemistry.

Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation

D. Stoppa-Lyonnet, C. Tlemsani, B. Buecher, 2015, Journal of Medical Genetics.

[Molecular biology of sarcoma and therapeutic choices].

J. Blay, I. Ray-Coquard, P. Cassier, 2015, Bulletin du Cancer.

Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation

D. Stoppa-Lyonnet, C. Tlemsani, B. Buecher, 2015, Journal of Medical Genetics.